Myriad Genetics reported $190.7M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Agilent USD 1.88B 43M Jun/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Bio-Rad Laboratories USD 656.4M 5.4M Sep/2026
Bruker USD 874M 35.5M Sep/2026
Danaher USD 6.55B 254M Sep/2026
Illumina USD 1.17B 10M Sep/2026
J&J USD 25.4B 89M Sep/2026
Mettler Toledo International USD 1.09B 60M Sep/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quest Diagnostics USD 3.1B 57M Sep/2026
Quidel USD 618.9M 12M Sep/2026
Repligen USD 209M 5M Sep/2026
Revvity USD 729M 680K Sep/2026
Standard Biotools USD 20.1M 996K Jun/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Veracyte USD 151.75M 1.43M Sep/2026
Waters USD 1.77B 130M Sep/2026